AXIS Capital Holdings Limited (NYSE:AXS – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $98.71.
A number of equities analysts recently commented on AXS shares. Jefferies Financial Group raised their target price on AXIS Capital from $88.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, October 9th. Bank of America boosted their price objective on AXIS Capital from $81.00 to $96.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. UBS Group raised their target price on shares of AXIS Capital from $92.00 to $98.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Keefe, Bruyette & Woods increased their price objective on shares of AXIS Capital from $94.00 to $96.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 6th. Finally, Wells Fargo & Company raised shares of AXIS Capital from an “underweight” rating to an “equal weight” rating and upped their target price for the stock from $78.00 to $89.00 in a report on Wednesday.
Read Our Latest Stock Analysis on AXIS Capital
Institutional Inflows and Outflows
AXIS Capital Price Performance
Shares of AXS opened at $91.77 on Thursday. The firm has a market cap of $7.68 billion, a PE ratio of 12.73, a P/E/G ratio of 0.31 and a beta of 0.94. AXIS Capital has a 1-year low of $53.49 and a 1-year high of $94.54. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.27. The firm has a fifty day simple moving average of $85.33 and a two-hundred day simple moving average of $78.08.
AXIS Capital (NYSE:AXS – Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $2.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.55 by $0.16. AXIS Capital had a net margin of 10.82% and a return on equity of 19.24%. The company had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter last year, the firm posted $2.34 earnings per share. On average, equities analysts anticipate that AXIS Capital will post 10.83 EPS for the current year.
AXIS Capital Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.44 per share. The ex-dividend date is Tuesday, December 31st. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.92%. AXIS Capital’s payout ratio is 24.41%.
About AXIS Capital
AXIS Capital Holdings Limited, through its subsidiaries, provides various specialty insurance and reinsurance products in Bermuda, the United States, and internationally. It operates through two segments, Insurance and Reinsurance. The Insurance segment offers professional insurance products that cover directors' and officers' liability, errors and omissions, employment practices, fiduciary, crime, professional indemnity, medical malpractice, and other financial insurance related coverages for commercial enterprises, financial institutions, not-for-profit organizations, and other professional service providers; and property insurance products for commercial buildings, residential premises, construction projects, property in transit, onshore renewable energy installations, and physical damage and business interruption following an act of terrorism.
Featured Articles
- Five stocks we like better than AXIS Capital
- How to Invest in Blue Chip Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Use Stock Screeners to Find Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- The Role Economic Reports Play in a Successful Investment Strategy
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for AXIS Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXIS Capital and related companies with MarketBeat.com's FREE daily email newsletter.